The bill prohibits physicians from performing gender transitioning and reassignment procedures on children under the age of eighteen, with specific exceptions for those born with medically verifiable genetic disorders of sex development. It outlines that such procedures include surgeries that sterilize the child, mastectomies, and the administration of certain prescription drugs that induce infertility. Additionally, the bill mandates that any health insurance policy issued after July 1, 2023, cannot cover these procedures for children.

Furthermore, the bill establishes that violations of these provisions can lead to the suspension or revocation of a physician's license. It amends existing laws to include these violations as grounds for disciplinary action against healthcare providers, including pharmacists. The act requires relevant state agencies to create rules for its implementation and specifies that it will take effect on July 1, 2023, with certain sections effective immediately upon the bill's passage.

Statutes affected:
Introduced: 33-24-122, 33-26-402